Select Publications

Book Chapters

Appay V; Sauce D; Kelleher AD, 2019, 'HIV Infection as a Model of Accelerated Immunosenescence', in Handbook of Immunosenescence, Springer International Publishing, pp. 1961 - 1989, http://dx.doi.org/10.1007/978-3-319-99375-1_50

Ognenovska K; Klemm V; Ledger S; Turville S; Symonds G; Kelleher A; Ahlenstiel CL, 2018, 'Mechanisms for Controlling HIV-1 infection: a Gene Therapy Approach', in In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders, http://dx.doi.org/10.5772/intechopen.72962

Appay V; Sauce D; Kelleher A, 2017, 'HIV Infection as a Model of Accelerated Immunosenescence.', in Bachtarzi H (ed.), Handbook of Immunosenescence Basic Understanding and Clinical Implications, http://dx.doi.org/10.1007/978-3-319-64597-1_50-1

Pinto A; Kelleher AD; Cooper DA, 2014, 'AIDS : Clinical Manifestations', in Encyclopaedia of Life Sciences, John Wiley & Sons, http://dx.doi.org/10.1002/9780470015902.a0002237.pub3

Alford J; Kelleher A, 2013, 'The Immunocompromised Patient', in Fulde G; Fulde S (ed.), Emergency Medicine: the Principles of Practice, Churchill Livingston, Sydney, pp. 862 - 889, https://www.elsevier.com/books/emergency-medicine/fulde/978-0-7295-8146-2

Kelleher AD; Cooper DA, 2012, 'Chapter 6 Acute HIV infection', in Sande's HIV/AIDS Medicine, Elsevier, pp. 77 - 88, http://dx.doi.org/10.1016/b978-1-4557-0695-2.00006-7

Kelleher A; Kelly M, 2009, 'Immune Restoration Diseases', in Hoy J; Lewin S; Post JJ; Street A (ed.), HIV Management in Australasia: a guide for clinical care, pp. 287 - 294

Alford J; Kelleher AD, 2009, 'The immunosuppressed patient', in Fulde G (ed.), Emergency Medicine, the Principles of Practice, Elsevier, Australia, pp. 665 - 686, http://shop.mja.com.au/

Alford J; Kelleher A, 2009, 'The immunosuppressed patient', in Emergency Medicine, Elsevier, pp. 665 - 686, http://dx.doi.org/10.1016/b978-0-7295-3876-3.10042-5

Kelleher AD; Cooper DA, 2008, 'Acute HIV Infection', in Volberding PA; Sande MA; Greene WC; Lange JMA (ed.), Global HIV/AIDS Medicine, Elsevier Inc, Philadelphia, PA, pp. 63 - 74

Kelleher AD; Cooper DA, 2008, 'CHAPTER 6 Acute HIV Infection', in Global HIV/AIDS Medicine, Elsevier, pp. 63 - 74, http://dx.doi.org/10.1016/b978-1-4160-2882-6.50010-1

Ramacciotti TP; Kelleher AD; Cooper DA, 2008, 'Infeccion primaria por HIV. [Primary HIV-1 Infection]', in Benettuci JA (ed.), SIDA y Enfermedades Associadas (AIDS and Infectious Diseases), 3a edicion., FUNDAI, Buenos Aires, pp. 155 - 170

Kelleher AD; Cooper DA, 2007, 'Acute HIV Infection', in Global HIV AIDS Medicine, pp. 63 - 74, http://dx.doi.org/10.1016/B978-1-4160-2882-6.50010-1

Ramacciotti TP; Smith DE; Emery S; Kelleher AD; Cooper DA, 2005, 'Therapeutic vaccination in PHI', in Jenssen H; Jager H (ed.), Primary HIV Infection ? Pathology, Diagnosis, Management, Thieme, Stuttgart, pp. 48 - 63

Kelleher A; Orth D, 1997, 'Early HIV-induced immune depletion', in Stewart GJ (ed.), Managing HIV, Medical Journal of Australia

Stewart GJ; Irvine SS; Scott M; Kelleher A; Marriot D; McKnight I; Pethebridge AM; Wodak A; Ziegler J, 1997, 'Strategies in managing HIV', in Stewart GJ (ed.), Managing HIV

Journal articles

Obeng BM; Kouyos RD; Kusejko K; Salazar-Vizcaya L; Günthard HF; Kelleher AD; Di Giallonardo F, 2025, 'Threshold sensitivity analysis for HIV-1 transmission cluster detection using different genomic regions and subtypes', Virology, 608, http://dx.doi.org/10.1016/j.virol.2025.110558

Jacka BP; Cheng QL; Schiavone B; Darley DR; Kelleher AD; Dore GJ; Matthews GV, 2025, 'Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf142

O'neill RS; Gardner L; Kelleher A; Pamphlett R; Girgis L; Stoita A, 2025, 'Perplexing case of abdominal pain with eosinophilia and fasciitis', Gut, 74, pp. 570 - 651, http://dx.doi.org/10.1136/gutjnl-2024-332580

Papot E; Tovar-Sanchez T; Woods J; Thaurignac G; Eriobu N; Borok M; Kaplan R; Avihingsanon A; Azwa I; Grinsztejng B; Kumarasamy N; Sokhela S; Mpoudi-Etame M; Arriaga M; Jacoby S; Matthews GV; Losso MH; Khoo S; Calmy A; Kouanfack C; Ayouba A; Petoumenos K; Venter WDF; Delaporte E; Polizzotto MN, 2025, 'SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa', AIDS, 39, pp. 448 - 456, http://dx.doi.org/10.1097/QAD.0000000000004068

Prideaux L; Sandeman M; Stratton H; Kelleher AD; Smith S; Hanson J, 2025, 'Melioidosis in people living with diabetes; clinical presentation, clinical course and implications for patient management', Acta Tropica, 263, pp. 107559, http://dx.doi.org/10.1016/j.actatropica.2025.107559

Young C; Singh M; Jackson KJL; Field MA; Peters TJ; Angioletti-Uberti S; Frenkel D; Ravishankar S; Gupta M; Wang JJ; Agapiou D; Faulks ML; Al-Eryani G; Luciani F; Gordon TP; Reed JH; Danta M; Carr A; Kelleher AD; Dore GJ; Matthews G; Brink R; Bull RA; Suan D; Goodnow CC, 2025, 'A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease', Immunity, 58, pp. 412 - 430.e10, http://dx.doi.org/10.1016/j.immuni.2024.12.011

Mazigi O; Langley DB; Henry JY; Burnett DL; Sobti M; Walker GJ; Rouet R; Balachandran H; Lenthall H; Jackson J; Ubiparipovic S; Schofield P; Brown SHJ; Schulz SR; Hoffmann M; Pöhlmann S; Post J; Martinello M; Ahlenstiel G; Kelleher A; Rawlinson WD; Turville SG; Bull RA; Stewart AG; Jäck HM; Goodnow CC; Christ D, 2025, 'Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies', Proceedings of the National Academy of Sciences of the United States of America, 122, http://dx.doi.org/10.1073/pnas.2417544121

Bowden-Reid E; Moles E; Kelleher A; Ahlenstiel C, 2025, 'Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV', Drug Delivery and Translational Research, http://dx.doi.org/10.1007/s13346-025-01788-x

Dhenni R; Hoppé AC; Reynaldi A; Kyaw W; Handoko NT; Grootveld AK; Keith YH; Bhattacharyya ND; Ahel HI; Telfser AJ; McCorkindale AN; Yazar S; Bui CHT; Smith JT; Khoo WH; Boyd M; Obeid S; Milner B; Starr M; Brilot F; Milogiannakis V; Akerman A; Aggarwal A; Davenport MP; Deenick EK; Chaffer CL; Croucher PI; Brink R; Goldstein LD; Cromer D; Turville SG; Kelleher AD; Venturi V; Munier CML; Phan TG, 2025, 'Macrophages direct location-dependent recall of B cell memory to vaccination', Cell, pp. S0092-8674(25)00407-6, http://dx.doi.org/10.1016/j.cell.2025.04.005

Keen P; Nigro SJ; Chan C; Bavinton BR; Aung HL; Holt M; Guy R; Amin J; Broady TR; Costello J; Kelleher AD; Treloar C; Varma R; Vaughan M; Delpech V; Grulich AE, 2025, 'Progress towards the UNAIDS 2030 HIV prevention target in New South Wales, Australia: a population-based study', The Lancet Regional Health - Western Pacific, 57, pp. 101535 - 101535, http://dx.doi.org/10.1016/j.lanwpc.2025.101535

Shrestha LB; Tungatt K; Aggarwal A; Stubis A; Fewings NL; Fichter C; Akerman A; Rodrigo C; Tedla N; Lee S; Lloyd AR; Brilot F; Britton WJ; Kelleher A; Caterson ID; Douglas MW; Rockett R; Tangye SG; Triccas JA; Turville SG; Sandgren KJ; Bull RA; Cunningham AL; Sorrell T; Maclean M; Camilleri J; Douglas M; Song Y; Mao L; Phu A; Sigmund A; Beard S; Hunt S; Vande More AM; Kandasamy R; Kok J; Byrne J; Lloyd A; Tangye S; O'Sullivan M; Steain M; Baird S; Phetsouphanh C; Zhao Y, 2024, 'Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants', Ebiomedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105461

Akerman A; Fichter C; Milogiannakis V; Esneau C; Silva MR; Ison T; Lopez JA; Naing Z; Caguicla J; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Boss T; Condylios A; Yeang M; Sato K; Bartlett NN; Darley D; Matthews G; Stark DJ; Promsri S; Rawlinson WD; Murrell B; Kelleher AD; Dwyer D; Sintchenko V; Kok J; Ellis S; Marris K; Knight E; Hoad VC; Irving DO; Gosbell I; Brilot F; Wood J; Aggarwal A; Turville SG, 2024, 'Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic', Ebiomedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105415

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8

Cross GB; Sari IP; Burkill SM; Yap CW; Nguyen H; Quyet D; Dalay VB; Gutierrez E; Balanag VM; Castillo RJ; Chang CC; Kelleher AD; O’Doherty J; Paton NI, 2024, 'PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-54419-3

Kelly-Hanku A; Songtaweesin WN; Palmares ML; Bartlett AW; Gare J; Sta Maria MK; Thanh Thuy CT; Gideon N; Boma GV; Kaima P; Da Silva De Jesus B; Devi R; Kelleher AD; Puthanakit T, 2024, 'The urgency of now to end HIV vertical transmission for pregnant and breastfeeding women and their children in Asia and the Pacific', Lancet Regional Health Western Pacific, 53, http://dx.doi.org/10.1016/j.lanwpc.2024.101248

Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Templeton DJ; Zablotska-Manos I; Hoy J; Bloch M; Baker D; Brown G; Grulich A; Bavinton B; Pinto AN; Orth D; Roth N; Moore R; Tee BK; Pell C; McNulty A; Doong N; Triffitt K; Koelsch KK; Wilson D; Emery S; Kelleher A; Cooper DA; Grinsztejn B; Zablotska IB, 2024, 'Condom Failure Among HIV-Negative Men in Serodiscordant Relationships in Australia, Brazil, and Thailand', AIDS and Behavior, 28, pp. 3587 - 3595, http://dx.doi.org/10.1007/s10461-024-04431-x

Horsburgh BA; Walker GJ; Kelleher A; Lloyd AR; Bull RA; Giallonardo FD, 2024, 'Next-Generation Sequencing Methods for Near-Real-Time Molecular Epidemiology of HIV and HCV', Reviews in Medical Virology, 34, http://dx.doi.org/10.1002/rmv.70001

Wang TT; Hirons A; Doerflinger M; Morris KV; Ledger S; Purcell DFJ; Kelleher AD; Ahlenstiel CL, 2024, 'Current State of Therapeutics for HTLV-1', Viruses, 16, http://dx.doi.org/10.3390/v16101616

Matthews G; Jacoby S; Borok M; Eriobu N; Kaplan R; Kumarasamy N; Bennet JA; Avihingsanon A; Chetchotisakd P; Wagner Cardoso S; Azwa I; Losso M; Brown D; Arlinda D; Hutchinson J; Kelleher A; Cisse M; Dao S; Polizzotto M; Emery S; Law M; Papot E; Karyana M; Lupo S; Solari AM; Grinsztejn B; Wolff M; Andrade-Villanueva J; Mosqueda Gómez JL; Chow TS; Mohapi L; Yunihastuti E; Hadi U; Katu S; Subronto YW; Lane HC; Perelis L, 2024, 'Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial', Lancet HIV, 11, pp. e436 - e448, http://dx.doi.org/10.1016/S2352-3018(24)00089-4

King JM; Giallonardo FD; Shaik A; McGregor S; Yeung JYK; Sivaruban T; Lee FJ; Cunningham P; Dwyer DE; Nigro SJ; Grulich AE; Kelleher AD, 2024, 'Low HIV drug resistance prevalence among recently diagnosed HIV-positive men who have sex with men in a setting of high PrEP use', Journal of the International AIDS Society, 27, http://dx.doi.org/10.1002/jia2.26308

Jensen TO; Murray TA; Grandits GA; Jain MK; Grund B; Shaw-Saliba K; Matthay MA; Abassi M; Ardelt M; Baker JV; Chen P; Dewar RL; Goodman AL; Hatlen TJ; Highbarger HC; Holodniy M; Lallemand P; Laverdure S; Leshnower BG; Looney D; Moschopoulos CD; Mugerwa H; Murray DD; Mylonakis E; Nagy-Agren S; Rehman MT; Rupert A; Stevens R; Turville S; Weintrob A; Wick K; Lundgren J; Ko ER; Sahner D; Tierney J; Vogel SE; Herpin BR; Smolskis MC; McKay LA; Cahill K; Crew P; Sardana R; Raim SS; Hensely L; Lorenzo J; Mock R; Zuckerman J; Atri N; Miller M; Vallee D; Chung L; Kang N; Barrett K; Adam SJ; Read S; Draghia-Akli R; Currier J; Hughes E; Harrigan RH; Amos L; Carlsen A; Carter A; Collins G; Davis B; Denning E; DuChene A; Eckroth K; Engen N; Frase A; Gandits G; Harrison M; Hurlbut N; Kaiser P; Koopmeiners J; Larson G; Meger S; Mistry SS; Murray T; Nelson R; Quan K; Quan SF; Reilly C; Siegel L; Thompson G; Vock D; Walski J; Gelijns AC; Moskowitz AJ; Bagiella E; Moquete E; O'Sullivan K; Marks ME; Accardi E; Kinzel E; Burris S; Bedoya G; Gupta L; Overbey JR; Santos M; Gillinov MA, 2024, 'Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study', Lancet Microbe, 5, pp. e559 - e569, http://dx.doi.org/10.1016/S2666-5247(24)00015-6

Alagaratnam J; Stöhr W; Hamlyn E; Porter K; Toombs J; Heslegrave A; Zetterberg H; Gisslén M; Underwood J; Schechter M; Kaleebu P; Tambussi G; Kinloch S; Miro JM; Kelleher AD; Babiker A; Frater J; Winston A; Fidler S, 2024, 'Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial', Journal of Virus Eradication, 10, http://dx.doi.org/10.1016/j.jve.2024.100381

Cross GB; O’ Doherty J; Chang CC; Kelleher AD; Paton NI, 2024, 'Does PET-CT Have a Role in the Evaluation of Tuberculosis Treatment in Phase 2 Clinical Trials', Journal of Infectious Diseases, 229, pp. 1229 - 1238, http://dx.doi.org/10.1093/infdis/jiad425

Kitawi R; Ledger S; Kelleher AD; Ahlenstiel CL, 2024, 'Advances in HIV Gene Therapy', International Journal of Molecular Sciences, 25, http://dx.doi.org/10.3390/ijms25052771

Obeng BM; Kelleher AD; Di Giallonardo F, 2024, 'Molecular epidemiology to aid virtual elimination of HIV transmission in Australia', Virus Research, 341, http://dx.doi.org/10.1016/j.virusres.2024.199310

Chaganti J; Poudel G; Cysique LA; Dore GJ; Kelleher A; Matthews G; Darley D; Byrne A; Jakabek D; Zhang X; Lewis M; Jha N; Brew BJ, 2024, 'Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: potential biomarkers and a window into pathogenesis', Frontiers in Neurology, 15, http://dx.doi.org/10.3389/fneur.2024.1350848

Kelleher AD; Crowe S; Cunningham A, 2024, 'David Albert Cooper 1949–2018', Historical Records of Australian Science, 36, http://dx.doi.org/10.1071/hr23032

Pathmanandavel K; Le S; Xie S; Alves M; Foley E; Kelleher A; Zaunders J; Carr A; Tong W; Breit S; Sewell W; Kane A, 2024, 'Novel clinical applications of functional assays to measure antigen-specific cellular immunity', Pathology, 56, pp. s27, http://dx.doi.org/10.1016/j.pathol.2023.12.101

Rouet R; Henry JY; Johansen MD; Sobti M; Balachandran H; Langley DB; Walker GJ; Lenthall H; Jackson J; Ubiparipovic S; Mazigi O; Schofield P; Burnett DL; Brown SHJ; Martinello M; Hudson B; Gilroy N; Post JJ; Kelleher A; Jäck HM; Goodnow CC; Turville SG; Rawlinson WD; Bull RA; Stewart AG; Hansbro PM; Christ D, 2023, 'Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-36295-5

Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', Plos One, 18, http://dx.doi.org/10.1371/journal.pone.0289907

Loprete J; Richardson R; Bramah V; Comben S; Li T; Beiglari L; O'Neill R; McEwan C; Carr A; Tong W; Campbell D; Wong M; Evans L; Post J; Torda A; Kane A; Kelleher A; Wainstein B; McMullan B; Law M, 2023, 'Delabeling, safety, and impact of β-lactam allergy testing: A systematic review', Journal of Allergy and Clinical Immunology Global, 2, http://dx.doi.org/10.1016/j.jacig.2023.100160

Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Kelleher A; Templeton DJ; Zablotska-Manos I; Hoy J; McNulty A; Baker D; Brown G; Grulich A; Bavinton B, 2023, 'Agreements, Behaviour, and Change: Sex Outside the Relationship in Male HIV-negative Partners in HIV Serodiscordant Relationships in Australia, Brazil, and Thailand', AIDS and Behavior, 27, pp. 3098 - 3108, http://dx.doi.org/10.1007/s10461-023-04030-2

Brown SM; Barkauskas CE; Grund B; Sharma S; Phillips AN; Leither L; Peltan ID; Lanspa M; Gilstrap DL; Mourad A; Lane K; Beitler JR; Serra AL; Garcia I; Almasri E; Fayed M; Hubel K; Harris ES; Middleton EA; Barrios MAG; Mathews KS; Goel NN; Acquah S; Mosier J; Hypes C; Salvagio Campbell E; Khan A; Hough CL; Wilson JG; Levitt JE; Duggal A; Dugar S; Goodwin AJ; Terry C; Chen P; Torbati S; Iyer N; Sandkovsky US; Johnson NJ; Robinson BRH; Matthay MA; Aggarwal NR; Douglas IS; Casey JD; Hache-Marliere M; Georges Youssef J; Nkemdirim W; Leshnower B; Awan O; Pannu S; O'Mahony DS; Manian P; Awori Hayanga JW; Wortmann GW; Tomazini BM; Miller RF; Jensen JU; Murray DD; Bickell NA; Zatakia J; Burris S; Higgs ES; Natarajan V; Dewar RL; Schechner A; Kang N; Arenas-Pinto A; Hudson F; Ginde AA; Self WH; Rogers AJ; Oldmixon CF; Morin H; Sanchez A; Weintrob AC; Cavalcanti AB; Davis-Karim A; Engen N; Denning E; Taylor Thompson B; Gelijns AC; Kan V; Davey VJ; Lundgren JD; Babiker AG; Neaton JD; Lane HC; Tierney J; Vogel SE; McNay LA; Cahill K; Crew P; Sardana R; Segal Raim S; Shaw-Saliba K; Atri N; Miller M; Vallee D; Chung L; Delph Y, 2023, 'Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial', Lancet Respiratory Medicine, 11, pp. 791 - 803, http://dx.doi.org/10.1016/S2213-2600(23)00147-9

Bowden-Reid E; Ledger S; Zhang Y; Di Giallonardo F; Aggarwal A; Stella AO; Akerman A; Milogiannakis V; Walker G; Rawlinson W; Turville S; Kelleher AD; Ahlenstiel C, 2023, 'Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2', Antiviral Research, 217, http://dx.doi.org/10.1016/j.antiviral.2023.105677


Back to profile page